Differential Roles of Insulin and IGF-1 Receptors in Adipose Tissue Development and Function
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
To determine the roles of insulin and insulin-like growth factor 1 (IGF-1) action in adipose tissue, we created mice lacking the insulin receptor (IR), IGF-1 receptor (IGF1R), or both using Cre-recombinase driven by the adiponectin promoter. Mice lacking IGF1R only (F-IGFRKO) had a ∼25% reduction in white adipose tissue (WAT) and brown adipose tissue (BAT), whereas mice lacking both IR and IGF1R (F-IR/IGFRKO) showed an almost complete absence of WAT and BAT. Interestingly, mice lacking only the IR (F-IRKO) had a 95% reduction in WAT, but a paradoxical 50% increase in BAT with accumulation of large unilocular lipid droplets. Both F-IRKO and F-IR/IGFRKO mice were unable to maintain body temperature in the cold and developed severe diabetes, ectopic lipid accumulation in liver and muscle, and pancreatic islet hyperplasia. Leptin treatment normalized blood glucose levels in both groups. Glucose levels also improved spontaneously by 1 year of age, despite sustained lipodystrophy and insulin resistance. Thus, loss of IR is sufficient to disrupt white fat formation, but not brown fat formation and/or maintenance, although it is required for normal BAT function and temperature homeostasis. IGF1R has only a modest contribution to both WAT and BAT formation and function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Adipose-specific IR knockout decreases mitochondrial content and oxygen consumption in brown AT (BAT), while depleting white AT (WAT) mass by over 90% (38).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Betatrophin: A Hormone that Controls Pancreatic β Cell Proliferation
Yi, P., Park, J.-S., & Melton, D. A. (2013) · Cell · doi:10.1016/j.cell.2013.04.008 · Cited by 449 · cited 2×
“Expression of Angptl8/betatrophin (also known as RIFL or lipasin (22; 23)) was increased by 1.”
RetractedA Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,237 · cited 1×
“Adiponectin expression is also the highest in mature adipocytes (30) and low in preadipocytes (31,32), leading to progressive gene recombination through the differentiation process.”
BackgroundAdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity
Hu, E., Liang, P., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10697 · Cited by 2,238 · cited 1×
“Adiponectin expression is also the highest in mature adipocytes (30) and low in preadipocytes (31,32), leading to progressive gene recombination through the differentiation process.”
BackgroundTracking adipogenesis during white adipose tissue development, expansion and regeneration
Wang, Q. A., Tao, C., Gupta, R. K., & Scherer, P. E. (2013) · Nature Medicine · doi:10.1038/nm.3324 · Cited by 1,262 · cited 1×
“Lineage tracing studies using the adiponectin promoter indicate that adipocyte commitment in subcutaneous adipose tissue takes place during embryonic days 14–18, but in visceral adipose tissue occurs gradually during the postnatal period (33).”
BackgroundSkeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diab.46.6.983 · Cited by 1,179 · cited 1×
“Ectopic lipid accumulation in muscle is often associated with insulin resistance (27), but usually this occurs without muscle atrophy.”
BackgroundSkeletal muscle triglyceride levels are inversely related to insulin action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diabetes.46.6.983 · Cited by 1,179
Gavin, J. R., Roth, J., Neville, D. M., De Meyts, P., & Buell, D. N. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.1.84 · Cited by 1,040 · cited 1×
“We recently demonstrated that loss of IR in muscle causes significant muscle atrophy (15), and it is well known that hyperinsulinemia can induce IR degradation (28; 29).”
BackgroundLeptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S., & Goldstein, J. L. (1999) · Nature · doi:10.1038/43448 · Cited by 1,038 · cited 1×
“Leptin treatment has been shown to reverse hyperglycemia in mice and humans with lipoatrophic diabetes (18-21).”
BackgroundHe, W., Barak, Y., Hevener, A., Olson, P., Liao, D., Le, J., Nelson, M., Ong, E., Olefsky, J. M., & Evans, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536828100 · Cited by 976 · cited 1×
“This is similar to mice with Pparγ deleted using aP2-Cre, which display modest fat reduction and normal glucose levels (34; 35), whereas mice with Pparγ deletion driven by Adipo-Cre exhibit almost a complete loss of WAT and BAT, marked hepatic steatosis and severe diabetes (36).”
MethodBlüher, M., Michael, M. D., Peroni, O. D., Ueki, K., Carter, N., Kahn, B. B., & Kahn, C. R. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00199-5 · Cited by 806 · cited 2×
“Fat-specific deletion of IR results in reduced WAT and BAT mass (6,7), whereas mice with a fat-specific deletion of IGF1R alone have been reported to have slightly increased adipose tissue mass associated with increased overall body growth (8).”
BackgroundSelf-citationLeptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy
Petersen, K. F., Oral, E. A., Dufour, S., Befroy, D., Ariyan, C., Yu, C., Cline, G. W., DePaoli, A. M., Taylor, S. I., Gorden, P., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215001 · Cited by 800 · cited 1×
“Leptin replacement reduces blood glucose levels and hepatic steatosis in human patients with lipodystrophy (38), and leptin replacement also normalizes blood glucose levels in F-IRKO and F-IR/IGFRKO mice.”
BackgroundInsulin Resistance and Hyperinsulinemia
Shanik, M. H., Xu, Y., Škrha, J., Dankner, R., Zick, Y., & Roth, J. (2008) · Diabetes Care · doi:10.2337/dc08-s264 · Cited by 791
Zisman, A., Peroni, O. D., Abel, E. D., Michael, M. D., Mauvais-Jarvis, F., Lowell, B. B., Wojtaszewski, J. F. P., Hirshman, M. F., Virkamaki, A., Goodyear, L. J., et al. (2000) · Nature Medicine · doi:10.1038/78693 · Cited by 743 · cited 1×
“2A and B), which could further exacerbate insulin resistance and glucose intolerance (26).”
BackgroundSelf-citationTranscriptional Control of Adipose Lipid Handling by IRF4
Eguchi, J., Wang, X., Yu, S., Kershaw, E. E., Chiu, P. C., Dushay, J., Estall, J. L., Klein, U., Maratos-Flier, E., & Rosen, E. D. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.005 · Cited by 606 · cited 2×
“Fat-specific IR, IGF1R, and IR/IGF1R knockout (F-IRKO, F-IGFRKO, and F-IR/IGFRKO, respectively) mice were generated by breeding IR/IGF1R mice on a C57BL/6-129Sv genetic background (9) with mice carrying Cre recombinase driven by the adiponectin promoter (Adipo-Cre) on a C57BL/6 background (12).”
BackgroundMethodJones, J. R., Barrick, C., Kim, K.-A., Lindner, J., Blondeau, B., Fujimoto, Y., Shiota, M., Kesterson, R. A., Kahn, B. B., & Magnuson, M. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306743102 · Cited by 486
Lessons on Conditional Gene Targeting in Mouse Adipose Tissue
Lee, K. Y., Russell, S. J., Ussar, S., Boucher, J., Vernochet, C., Mori, M. A., Smyth, G., Rourk, M., Cederquist, C., Rosen, E. D., et al. (2013) · Diabetes · doi:10.2337/db12-1089 · Cited by 328 · cited 1×
“This is, in part, due to the higher expression and recombination efficiency of adiponectindriven Cre and to the greater specificity of its expression in fat (10,11,13).”
BackgroundSelf-citationLipodystrophy: pathophysiology and advances in treatment
Fiorenza, C. G., Chou, S. H., & Mantzoros, C. S. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.199 · Cited by 255 · cited 1×
“The lipodystrophic syndrome observed in F-IRKO and F-IR/IGFRKO mice is similar to metabolic derangement of human generalized lipodystrophy including low leptin levels, marked insulin resistance, hyperlipidemia, and fatty liver disease (21,37).”
BackgroundLipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARγ
Wang, F., Mullican, S. E., DiSpirito, J. R., Peed, L. C., & Lazar, M. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314863110 · Cited by 255 · cited 1×
“This is similar to mice with Pparγ deleted using aP2-Cre, which display modest fat reduction and normal glucose levels (34; 35), whereas mice with Pparγ deletion driven by Adipo-Cre exhibit almost a complete loss of WAT and BAT, marked hepatic steatosis and severe diabetes (36).”
MethodEbihara, K., Ogawa, Y., Masuzaki, H., Shintani, M., Miyanaga, F., Aizawa-Abe, M., Hayashi, T., Hosoda, K., Inoue, G., Yoshimasa, Y., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.6.1440 · Cited by 240
SerpinB1 Promotes Pancreatic β Cell Proliferation
El Ouaamari, A., Dirice, E., Gedeon, N., Hu, J., Zhou, J.-Y., Shirakawa, J., Hou, L., Goodman, J., Karampelias, C., Qiang, G., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.001 · Cited by 234
Self-citationThe development and endocrine functions of adipose tissue
Poulos, S. P., Hausman, D. B., & Hausman, G. J. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.12.011 · Cited by 225 · cited 1×
“Insulin and insulin-like growth factor 1 (IGF-1) play important roles in the development and differentiation of white and brown adipose tissue (WAT and BAT) (1,2).”
BackgroundGuerra, C., Navarro, P., Valverde, A. M., Arribas, M., Brüning, J., Kozak, L. P., Kahn, C. R., & Benito, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13103 · Cited by 224 · cited 1×
“Fat-specific deletion of IR results in reduced WAT and BAT mass (6,7), whereas mice with a fat-specific deletion of IGF1R alone have been reported to have slightly increased adipose tissue mass associated with increased overall body growth (8).”
BackgroundSelf-citationLipodystrophy: metabolic insights from a rare disorder
Huang-Doran, I., Sleigh, A., Rochford, J. J., O'Rahilly, S., & Savage, D. B. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0272 · Cited by 215 · cited 1×
“The lipodystrophic syndrome observed in F-IRKO and F-IR/IGFRKO mice is similar to metabolic derangement of human generalized lipodystrophy including low leptin levels, marked insulin resistance, hyperlipidemia and fatty liver disease (21; 37).”
BackgroundSite and mechanism of leptin action in a rodent form of congenital lipodystrophy
Asilmaz, E., Cohen, P., Miyazaki, M., Dobrzyn, P., Ueki, K., Fayzikhodjaeva, G., Soukas, A. A., Kahn, C. R., Ntambi, J. M., Socci, N. D., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19511 · Cited by 210 · cited 1×
“Leptin treatment has been shown to reverse hyperglycemia in mice and humans with lipoatrophic diabetes (18-21).”
BackgroundSelf-citationSite and mechanism of leptin action in a rodent form of congenital lipodystrophy
Asilmaz, E., Cohen, P., Miyazaki, M., Dobrzyn, P., Ueki, K., Fayzikhodjaeva, G., Soukas, A. A., Kahn, C. R., Ntambi, J. M., Socci, N. D., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419511 · Cited by 210
Self-citationCharacterization of Cre recombinase models for the study of adipose tissue
Jeffery, E., Berry, R., Church, C. D., Yu, S., Shook, B. A., Horsley, V., Rosen, E. D., & Rodeheffer, M. S. (2014) · Adipocyte · doi:10.4161/adip.29674 · Cited by 209 · cited 1×
“This is, in part, due to the higher expression and recombination efficiency of adiponectindriven Cre and to the greater specificity of its expression in fat (10,11,13).”
ANGPTL8/Betatrophin Does Not Control Pancreatic Beta Cell Expansion
Gusarova, V., Alexa, C. A., Na, E., Stevis, P. E., Xin, Y., Bonner-Weir, S., Cohen, J. C., Hobbs, H. H., Murphy, A. J., Yancopoulos, G. D., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.027 · Cited by 202 · cited 1×
“Angptl8/ betatrophin (22,23) and SerpinB1 (24) have recently been shown to be b-cell growth factors that contribute to the islet hyperplasia in insulin-resistant states.”
BackgroundSiddle, K. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00034 · Cited by 178 · cited 1×
“Furthermore, whereas insulin and IGF-1 bind with higher affinity to their cognate receptors, insulin can also bind and activate the IGF1R and vice versa (3,4).”
BackgroundVernochet, C., Damilano, F., Mourier, A., Bezy, O., Mori, M. A., Smyth, G., Rosenzweig, A., Larsson, N., & Kahn, C. R. (2014) · The FASEB Journal · doi:10.1096/fj.14-253971 · Cited by 174 · cited 1×
“BAT oxygen consumption rate was assessed using freshly isolated mouse BAT as previously described (17).”
MethodSelf-citationDifferential role of insulin/IGF-1 receptor signaling in muscle growth and glucose homeostasis
O’Neill, B. T., Lauritzen, H. P. M. M., Hirshman, M. F., Smyth, G., Goodyear, L. J., & Kahn, C. R. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.037 · Cited by 171
Self-citationBoucher, J., Tseng, Y.-H., & Kahn, C. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118620 · Cited by 162 · cited 3×
“Furthermore, whereas insulin and IGF-1 bind with higher affinity to their cognate receptors, insulin can also bind and activate the IGF1R and vice versa (3,4).”
BackgroundSelf-citationBoucher, J., Mori, M. A., Lee, K. Y., Smyth, G., Liew, C. W., Macotela, Y., Rourk, M., Bluher, M., Russell, S. J., & Kahn, C. R. (2012) · Nature Communications · doi:10.1038/ncomms1905 · Cited by 142 · cited 5×
“Generalized Lipodystrophy in Mice Lacking IR in the Fat Mice with a homozygous fat-specific knockout of the IR, IGF1R, or both were generated by breeding mice with IR and IGF1R floxed alleles (9) and mice carrying a Crerecombinase transgene driven by the adiponectin promoter (12).”
BackgroundMethodInfluentialSelf-citationEntingh-Pearsall, A., & Kahn, C. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313201200 · Cited by 140
Self-citationAutocrine IGF-1 Action in Adipocytes Controls Systemic IGF-1 Concentrations and Growth
Klöting, N., Koch, L., Wunderlich, T., Kern, M., Ruschke, K., Krone, W., Brüning, J. C., & Blüher, M. (2008) · Diabetes · doi:10.2337/db07-1538 · Cited by 140 · cited 2×
“Fat-specific deletion of IR results in reduced WAT and BAT mass (6,7), whereas mice with a fat-specific deletion of IGF1R alone have been reported to have slightly increased adipose tissue mass associated with increased overall body growth (8).”
BackgroundLiver-derived systemic factors drive β cell hyperplasia in insulin-resistant states
El Ouaamari, A., Kawamori, D., Dirice, E., Liew, C. W., Shadrach, J. L., Hu, J., Katsuta, H., Hollister-Lock, J., Qian, W.-J., Wagers, A. J., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.01.007 · Cited by 136 · cited 1×
“Ki67+ beta cells were visualized by immunofluorescence microscopy and counted by a blinded observer (14).”
MethodSelf-citationKörner, A., Wabitsch, M., Seidel, B., Fischer‐Posovszky, P., Berthold, A., Stümvoll, M., Blüher, M., Kratzsch, J., & Kieß, W. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.064 · Cited by 133 · cited 1×
“18 mature adipocytes (30), and low in preadipocytes (31; 32), leading to progressive gene recombination through the differentiation process.”
BackgroundLipodystrophy Due to Adipose Tissue–Specific Insulin Receptor Knockout Results in Progressive NAFLD
Softic, S., Boucher, J., Solheim, M. H., Fujisaka, S., Haering, M.-F., Homan, E. P., Winnay, J., Perez-Atayde, A. R., & Kahn, C. R. (2016) · Diabetes · doi:10.2337/db16-0213 · Cited by 129 · cited 2×
“The effects of leptin are, at least in part, secondary to reduced food intake and can be mimicked by fasting alone (25).”
BackgroundSelf-citationInsulin-like growth factor I, growth hormone and insulin in white adipose tissue
Blüher, S., Kratzsch, J., & Kiess, W. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.011 · Cited by 114 · cited 1×
“Insulin and insulin-like growth factor 1 (IGF-1) play important roles in the development and differentiation of white and brown adipose tissue (WAT and BAT) (1,2).”
BackgroundGlucose Transporter 8 (GLUT8) Mediates Fructose-induced de Novo Lipogenesis and Macrosteatosis
DeBosch, B. J., Chen, Z., Saben, J. L., Finck, B. N., & Moley, K. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.527002 · Cited by 105 · cited 1×
“Skeletal muscle and heart TG were quantified as previously described (16).”
MethodA novel adipose-specific gene deletion model demonstrates potential pitfalls of existing methods
Mullican, S. E., Tomaru, T., Gaddis, C. A., Peed, L. C., Sundaram, A., & Lazar, M. A. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1267 · Cited by 83 · cited 1×
“This is, in part, due to the higher expression and recombination efficiency of adiponectindriven Cre and to the greater specificity of its expression in fat (10,11,13).”
Background
Cited by
Guo, S. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0327 · Cited by 623
Insulin: The Friend and the Foe in the Development of Type 2 Diabetes Mellitus
Rachdaoui, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051770 · Cited by 265
“, 17% to 45%) and are considered classic insulin-responsive tissues [40,41].”
BackgroundInsulin signaling in the hippocampus and amygdala regulates metabolism and neurobehavior
Soto, M., Cai, W., Konishi, M., & Kahn, C. R. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1817391116 · Cited by 243
Self-citationInsulin and Insulin Receptors in Adipose Tissue Development
Cignarelli, A., Genchi, V. A., Perrini, S., Natalicchio, A., Laviola, L., & Giorgino, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030759 · Cited by 219
“Conversely, permanent abrogation of INSR expression in adipocytes (AIRKO) resulted in severe lipodystrophy, with metabolic abnormalities such as IR, altered glucose homeostasis, dyslipidemia and fatty liver disease, leading to decreased lifespan [108,109].”
BackgroundInfluentialInsulin action at a molecular level – 100 years of progress
White, M. F., & Kahn, C. R. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101304 · Cited by 212
“The initial fat insulin receptor knockout mice (FIRKO) created using the aP2-Cre transgene displayed partial lipodystrophy and increased longevity [77,78], whereas FIRKO mice created using the more potent adiponectin-Cre displayed more severe lipodystrophy and NAFLD that progressed to NASH and liver dysplasia [79].”
BackgroundSelf-citation
Metadata
- Authors
- Boucher, J., Softic, S., El Ouaamari, A., Krumpoch, M. T., Kleinridders, A., Kulkarni, R. N., O’Neill, B. T., & Kahn, C. R.
- Affiliations
- Section on Integrative Physiology and Metabolism, Joslin Diabetes Center and Department of Medicine, Harvard Medical School, Boston, MA
- Boston Children's Hospital (US)
- Islet Cell and Regenerative Medicine, Joslin Diabetes Center and Department of Medicine, Harvard Medical School, Boston, MA
- Joslin Diabetes Center (US)
- Corresponding author
- Kahn, C. Ronald
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2016-05-13
- Volume
- 65
- Issue
- 8
- Pages
- 2201-2213
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC4955980
- OpenAlex
- W2367846133
- Cited by
- 154
- References
- 39
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 16 · 2023: 13 · 2022: 20 · 2021: 30 · 2020: 11 · 2019: 15 · 2018: 7 · 2017: 17 · 2016: 2
- FWCI
- 11.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (K08-DK-100543)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- insulin receptor, IGF-1 receptor, adipose tissue development, white adipose tissue, brown adipose tissue, insulin resistance, cold tolerance, thermogenesis, ectopic fat deposition, pancreatic islet hyperplasia, leptin, receptor knockout mice
- MeSH terms
- Adipose Tissue, Animals, Adipose Tissue, Brown, Hyperglycemia, Hyperlipidemias, Insulin, Lipodystrophy, Oxygen Consumption, Receptor, Insulin, Succinate Dehydrogenase, Radioimmunoprecipitation Assay, Receptor, IGF Type 1, Mice, Knockout, Leptin, Insulin-Secreting Cells, Mice, Adipose Tissue, White, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.